Gamma Medica closes $18M Series A round | Wall Street Beat

July 19, 2013 by Brad Perriello

Gamma Medica says it's closed an $18 million Series A funding round for its molecular breast imaging device. Wall Street Beat

Gamma Medica said it's closed a $16 million Series A round from Psilos Group Managers.

The Northridge, Calif.-based company said it plans to use the cash to expand the commercial footprint of its LumaGen molecular breast imaging device and the LumaGuide biopsy model.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.